(Q42557463)

2 November 2017

title

Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis (English)

1 reference

2 November 2017

1 reference

1 reference

1

J R Graybill

1 reference

2 November 2017

R Bocanegra

2

1 reference

2 November 2017

M Luther

series ordinal

3

1 reference

2 November 2017

publication date

1 August 1995

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

2 November 2017

published in

1 reference

2 November 2017

volume

14

1 reference

2 November 2017

issue

8

1 reference

2 November 2017

page(s)

700-703

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01690878

2 November 2017

exact match

0 references

cites work

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

1 reference

https://api.crossref.org/works/10.1007%2FBF01690878

Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01690878

Colony-stimulating factors and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01690878

Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01690878

Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01690878

Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy.

21 January 2018

1 reference

12 December 2020

Protective effect of human granulocyte colony stimulating factor (hG-CSF) on Candida, infections in normal and immunosuppressed mice

1 reference

12 December 2020

Granulocyte colony-stimulating factor protects control rats but not ethanol-fed rats from fatal pneumococcal pneumonia

1 reference

12 December 2020

Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections

1 reference

12 December 2020

Risk factors for hospital-acquired candidemia. A matched case-control study

1 reference

12 December 2020

In vivo activation of neutrophil function in hamsters by recombinant human granulocyte colony-stimulating factor.

1 reference

12 December 2020

Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF.

1 reference

12 December 2020

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

12 December 2020

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

12 December 2020

Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01690878

1 reference

Dimensions Publication ID

2 November 2017

1044973267

0 references

1 reference